Schäffler L, Imbach P, Rüdeberg A, Vassella F, Karbowski K
Eur J Cancer Clin Oncol. 1982 Sep;18(9):827-32. doi: 10.1016/0277-5379(82)90192-4.
One hundred and six EEG investigations were carried out in 17 children with various types of neoplastic disease without cerebral involvement during one or more courses of treatment with cytotoxic agents EEGs were recorded before and 24 hr after administration of the drugs. The EEGs were evaluated visually and by spectral analysis. A transient slowing of the dominant frequency in the alpha band by about 1 Hz and a decrease in the relative power of alpha activity by 20-30% was observed in only 4 patients. These children did not show any clinical or biochemical signs of neurotoxicity. The children did not receive the same antineoplastic treatment. One patient received very high dose methotrexate, 2 patients received vincristine combined with other cytotoxic agents and the other patient received L-asparaginase. It is suggested that EEG changes in patients receiving intravenous cytotoxic treatment usually occur only where there is pre-existing impairment of the blood--cerebrospinal fluid barrier or blood-brain barrier. No clinical signs of epilepsy, new epileptiform waves in the EEG or long-term changes in the background activity of the EEG were observed in this pilot study.
对17名患有各种类型肿瘤疾病且无脑转移的儿童进行了106次脑电图检查,这些儿童在接受一个或多个疗程的细胞毒性药物治疗期间,于用药前和用药后24小时记录脑电图。通过视觉和频谱分析对脑电图进行评估。仅4例患者出现α波优势频率短暂减慢约1Hz,α活动相对功率降低20%-30%。这些儿童未表现出任何神经毒性的临床或生化迹象。这些儿童接受的抗肿瘤治疗不尽相同。1例患者接受了高剂量甲氨蝶呤,2例患者接受长春新碱联合其他细胞毒性药物,另1例患者接受L-天冬酰胺酶治疗。提示接受静脉细胞毒性治疗的患者脑电图改变通常仅发生在血脑屏障或血脑脊液屏障已有损害的情况下。在这项初步研究中未观察到癫痫的临床体征、脑电图中新的癫痫样波或脑电图背景活动的长期改变。